{
    "ID": "15663-27-1",
    "cas_number": [
        "15663-27-1"
    ],
    "country": "Japan",
    "date_classified": "2009",
    "date_imported": "Sat Jul  4 18:35:18 2015",
    "descriptive_name": "(SP-4-2)-Diamminedichloroplatinum, (alias Cisplatin)",
    "file_path": "h21_mhlw_new_e.xls",
    "hazards": {
        "acute_aquatic_toxicity": {
            "classification": "Classification not possible",
            "hazard_id": 11.0,
            "hazard_name": "Hazardous to the aquatic environment Acute",
            "hazard_statement": " - ",
            "rationale": "No data available.",
            "signal_word": " - ",
            "symbol": " - "
        },
        "acute_toxicity_dermal": {
            "classification": "Classification not possible",
            "hazard_id": 1.0,
            "hazard_name": "Acute toxicity Dermal",
            "hazard_statement": " - ",
            "rationale": "No data available.",
            "signal_word": " - ",
            "symbol": " - "
        },
        "acute_toxicity_inhalation_dust": {
            "classification": "Classification not possible",
            "hazard_id": 1.0,
            "hazard_name": "Acute toxicity Inhalation: Dusts and mists",
            "hazard_statement": " - ",
            "rationale": "No data available.",
            "signal_word": " - ",
            "symbol": " - "
        },
        "acute_toxicity_inhalation_gas": {
            "classification": "Not applicable",
            "hazard_id": 1.0,
            "hazard_name": "Acute toxicity Inhalation: Gases",
            "hazard_statement": " - ",
            "rationale": "Solid (GHS definition)",
            "signal_word": " - ",
            "symbol": " - "
        },
        "acute_toxicity_inhalation_vapor": {
            "classification": "Classification not possible",
            "hazard_id": 1.0,
            "hazard_name": "Acute toxicity Inhalation: Vapours",
            "hazard_statement": " - ",
            "rationale": "No data available.",
            "signal_word": " - ",
            "symbol": " - "
        },
        "acute_toxicity_oral": {
            "classification": "Category 2",
            "hazard_id": 1.0,
            "hazard_name": "Acute toxicity Oral",
            "hazard_statement": "Fatal if swallowed",
            "rationale": "Based on a LD50 value of approximately 20 mg/kg for rats (EHC No. 125 (1991)), the substance was classified into Category 2.",
            "signal_word": "Danger",
            "symbol": "Skull and crossbones"
        },
        "aspiration_hazard": {
            "classification": "Classification not possible",
            "hazard_id": 10.0,
            "hazard_name": "Aspiration hazard",
            "hazard_statement": " - ",
            "rationale": "No data available.",
            "signal_word": " - ",
            "symbol": " - "
        },
        "carcinogenicity": {
            "classification": "Category 1B",
            "hazard_id": 6.0,
            "hazard_name": "Carcinogenicity",
            "hazard_statement": "May cause cancer",
            "rationale": "Based on the classification of \"Group 2A\" in IARC (IARC suppl. 7 (1987)), the substance was classified into Category 1B. No epidemiological test of the substance as a single agent are available. Among animal examinations, intraperitoneal administrations to mice increased the incidence of lung adenomas and similar treatments increased the incidence of skin papillomas in mice given promoting treatment of croton oil applied to the skin. In two tests, multiple intraperitoneal injections to rats induced leukaemia (IARC suppl. 7 (1987)).",
            "signal_word": "Danger",
            "symbol": "Health Hazard"
        },
        "chronic_aquatic_toxicity": {
            "classification": "Classification not possible",
            "hazard_id": 11.0,
            "hazard_name": "Hazardous to the aquatic environment Long-term",
            "hazard_statement": " - ",
            "rationale": "No data available.",
            "signal_word": " - ",
            "symbol": " - "
        },
        "corrosive_to_metals": {
            "classification": "Classification not possible",
            "hazard_id": 16.0,
            "hazard_name": "Corrosive to metals",
            "hazard_statement": " - ",
            "rationale": "Test methods applicable to solid substances are not available.",
            "signal_word": " - ",
            "symbol": " - "
        },
        "explosives": {
            "classification": "Not applicable",
            "hazard_id": 1.0,
            "hazard_name": "Explosives",
            "hazard_statement": " - ",
            "rationale": "There are no chemical groups associated with explosive properties present in the molecules.",
            "signal_word": " - ",
            "symbol": " - "
        },
        "flammable_aerosols": {
            "classification": "Not applicable",
            "hazard_id": 3.0,
            "hazard_name": "Aerosols",
            "hazard_statement": " - ",
            "rationale": "Not aerosol products.",
            "signal_word": " - ",
            "symbol": " - "
        },
        "flammable_gases": {
            "classification": "Not applicable",
            "hazard_id": 2.0,
            "hazard_name": "Flammable gases including chemically unstable gases",
            "hazard_statement": " - ",
            "rationale": "Solid (GHS definition)",
            "signal_word": " - ",
            "symbol": " - "
        },
        "flammable_liquids": {
            "classification": "Not applicable",
            "hazard_id": 6.0,
            "hazard_name": "Flammable liquids",
            "hazard_statement": " - ",
            "rationale": "Solid (GHS definition)",
            "signal_word": " - ",
            "symbol": " - "
        },
        "flammable_solids": {
            "classification": "Classification not possible",
            "hazard_id": 7.0,
            "hazard_name": "Flammable solids",
            "hazard_statement": " - ",
            "rationale": "No data available.",
            "signal_word": " - ",
            "symbol": " - "
        },
        "gases_under_pressure": {
            "classification": "Not applicable",
            "hazard_id": 5.0,
            "hazard_name": "Gases under pressure",
            "hazard_statement": " - ",
            "rationale": "Solid (GHS definition)",
            "signal_word": " - ",
            "symbol": " - "
        },
        "germ_cell_mutagenicity": {
            "classification": "Category 1B",
            "hazard_id": 5.0,
            "hazard_name": "Germ cell mutagenicity",
            "hazard_statement": "May cause genetic defects",
            "rationale": "Based on a positive result in a mouse spermatocyte chromosomal aberration test (in vivo test) (PATTY (5th, 2001)), the substance was classified into Category 1B. As relevant information, there are other in vivo test reports of a negative mouse dominant lethal test (IARC suppl. 7 (1987)), positive mouse and rat bone marrow chromosomal aberration tests (EHC No. 125 (1991), PATTY (5th, 2001)), a positive mouse bone marrow sister chromatid exchange test (EHC No. 125 (1991)), and a positive mouse somatic cell DNA adduct formation test (PATTY (5th, 2001)). From in vitro mutagenicity tests, there are reports of a positive Ames tests, a positive chromosomal aberration tests and a positive micronucleus tests (EHC No. 125 (1991), IARC vol. 26 (1981), NTP DB (access on Oct. 2009)).",
            "signal_word": "Danger",
            "symbol": "Health Hazard"
        },
        "hazardous_to_ozone": {
            "classification": "",
            "hazard_id": "",
            "hazard_name": "",
            "hazard_statement": "",
            "rationale": "",
            "signal_word": "",
            "symbol": ""
        },
        "organic_peroxides": {
            "classification": "Not applicable",
            "hazard_id": 15.0,
            "hazard_name": "Organic peroxides",
            "hazard_statement": " - ",
            "rationale": "Inorganic compound",
            "signal_word": " - ",
            "symbol": " - "
        },
        "oxidizing_gases": {
            "classification": "Not applicable",
            "hazard_id": 4.0,
            "hazard_name": "Oxidizing gases",
            "hazard_statement": " - ",
            "rationale": "Solid (GHS definition)",
            "signal_word": " - ",
            "symbol": " - "
        },
        "oxidizing_liquids": {
            "classification": "Not applicable",
            "hazard_id": 13.0,
            "hazard_name": "Oxidizing liquids",
            "hazard_statement": " - ",
            "rationale": "Solid (GHS definition)",
            "signal_word": " - ",
            "symbol": " - "
        },
        "oxidizing_solids": {
            "classification": "Classification not possible",
            "hazard_id": 14.0,
            "hazard_name": "Oxidizing solids",
            "hazard_statement": " - ",
            "rationale": "Classification is not possible since no data are available though the substance is inorganic compound containing halogen atoms (Cl).",
            "signal_word": " - ",
            "symbol": " - "
        },
        "pyrophoric_liquids": {
            "classification": "Not applicable",
            "hazard_id": 9.0,
            "hazard_name": "Pyrophoric liquids",
            "hazard_statement": " - ",
            "rationale": "Solid (GHS definition)",
            "signal_word": " - ",
            "symbol": " - "
        },
        "pyrophoric_solids": {
            "classification": "Classification not possible",
            "hazard_id": 10.0,
            "hazard_name": "Pyrophoric solids",
            "hazard_statement": " - ",
            "rationale": "No data available.",
            "signal_word": " - ",
            "symbol": " - "
        },
        "reproductive_toxicity": {
            "classification": "Category 1B, Additional category: Effects on or via lactation",
            "hazard_id": 7.0,
            "hazard_name": "Reproductive toxicity",
            "hazard_statement": "May damage fertility or the unborn child\nMay cause harm to breast-fed children",
            "rationale": "There are human case reports that among 13 women treated with cytostatic drugs containing the substance during the first trimester of pregnancy, lower birth weight was noted in two of five mothers who continued the pregnancy until child birth and spontaneous abortions occurred in 4 women (PATTY (5th, 2001)). The substance was shown to cause azoospermia within 2 months after initiation of treatment (HSDB (2009)). In the substance's package insert, it is reported that \"This drug should not be given to pregnant women and women suspected of being pregnant\", \"(in animal tests) teratogenic effects and increased fetal lethality in rats and increased fetal lethality in rabbits were observed and teratogenic and fetal lethal effects were reported in mice.\" \"If mothers take this drug, they must be instructed not to breast feed (the substance was reported to pass into breast milk\" (cisplatin drug RANDA Injection package insert (2009)). Based on this information, the substance was classified into Category 1A, \"Effects on or via lactation\".",
            "signal_word": "Danger",
            "symbol": "Health Hazard"
        },
        "respiratory_sensitizer": {
            "classification": "Classification not possible",
            "hazard_id": 4.0,
            "hazard_name": "Respiratory sensitization",
            "hazard_statement": " - ",
            "rationale": "Classification not possible due to lack of data for respiratory sensitization. There is a report of \"neutral complexes of platinum such as this substance are not allergenic, since they probably do not react with proteins to form a complete antigen\" (EHC 125 (1991)).\n",
            "signal_word": " - ",
            "symbol": " - "
        },
        "self_heating_substances": {
            "classification": "Classification not possible",
            "hazard_id": 11.0,
            "hazard_name": "Self-heating substances and mixtures",
            "hazard_statement": " - ",
            "rationale": "No data available.",
            "signal_word": " - ",
            "symbol": " - "
        },
        "self_reactive_substances": {
            "classification": "Not applicable",
            "hazard_id": 8.0,
            "hazard_name": "Self-reactive substances and mixtures",
            "hazard_statement": " - ",
            "rationale": "There are no chemical groups present in the molecule associated with explosive or self-reactive properties.",
            "signal_word": " - ",
            "symbol": " - "
        },
        "serious_eye_damage_irritation": {
            "classification": "Category 2A",
            "hazard_id": 3.0,
            "hazard_name": "Serious eye damage/eye irritation",
            "hazard_statement": "Causes serious eye irritation",
            "rationale": "Based on a result of \"severely irritating\" in a rabbit test (EHC No. 125 (1991)), the substance was classified into Category 2A. As relevant information, there is a report that the dusts of soluble platinum salts cause a burning sensation in the eyes, lacrimation, and conjunctival hyperemia, sometimes associated with photophobia, which suggests that the corneal epithelium may be involved (HSDB (2009)).",
            "signal_word": "Warning",
            "symbol": "Exclamation mark"
        },
        "skin_corrosion_irritation": {
            "classification": "Not classified",
            "hazard_id": 2.0,
            "hazard_name": "Skin corrosion/irritation",
            "hazard_statement": " - ",
            "rationale": "Based on a result of \"mild irritant\" with a skin primary irritation index of 0.13 in a rabbit patch test (24-hour application) (EHC No. 125 (1991)), the substance was classified as \"Not classified\" in JIS Classification (correspond to Category 3 in GHS classification).",
            "signal_word": " - ",
            "symbol": " - "
        },
        "skin_sensitizer": {
            "classification": "Not classified",
            "hazard_id": 4.0,
            "hazard_name": "Skin sensitization",
            "hazard_statement": " - ",
            "rationale": "Based on a report of \"neutral complexes of platinum such as this substance are not allergenic, since they probably do not react with proteins to form a complete antigen\" (EHC No. 125 (1991)), the substance was classified into Category 1.",
            "signal_word": " - ",
            "symbol": " - "
        },
        "substances_mixtures_emit_flammable_gas_in_contact_with_water": {
            "classification": "Not classified",
            "hazard_id": 12.0,
            "hazard_name": "Substances and mixtures which, in contact with water, emit flammable gases",
            "hazard_statement": " - ",
            "rationale": "Information is available that water solubility is 0.253 g/100 g (25 degC) (Merck (14th, 2006)) though it contains metals.",
            "signal_word": " - ",
            "symbol": " - "
        },
        "systemic_toxicity_repeat_exposure": {
            "classification": "Category 1 (bone marrow, kidney, nervous system, digestive system, systemic toxicity)",
            "hazard_id": 9.0,
            "hazard_name": "Specific target organ toxicity - Repeated exposure",
            "hazard_statement": "Cause damage to organs through prolonged or repeated exposure (bone marrow, kidney, nervous system, digestive system, systemic toxicity)",
            "rationale": "The substance was used as antineoplastic drug, so human toxicity data are available from adverse drug reaction reports for treated patients. There are no data for oral, dermal or inhalation routes of exposure. The following symptoms are reported as long term therapy effects; anemia, thrombocytopenia, leucopenia as toxicity to the bone marrow, remarkable decrease in glomerular filtration rate as toxicity to the kidney, peripheral neuropathy, optic neuritis, papilledema, vibration sensory and hyporeflexia of the ankle, epileptic seizure, marked nausea and vomiting, and gastrointestinal disorder as toxicity to the gut (PATTY (5th, 2001), PIM 132 (1992)). Based on all the data, the substance was classified into Category 1 (bone marrow, kidney, nervous system, alimentary system). In the substance's package insert, there are the following reports as significant adverse reactions; acute renal failure, myelosuppression such as pancytopenia, shock, anaphylactoid reaction, decreased hearing, hearing loss, tinnitus, papilledema, retrobulbar neuritis, cortical blindness, cerebral infarction, transient ischemic attack, hemolytic-uremic syndrome, myocardial infarction, angina pectoris, congestive heart failure, cardiac arrhythmia, hemolytic anemia, interstitial pneumonitis, syndrome of inappropriate secretion of antidiuretic hormone, fulminant hepatitis, hepatic dysfunction, jaundice, gastrointestinal hemorrhage, peptic ulcer, gastrointestinal perforation, acute pancreatitis, hyperglycemia, exacerbation of diabetes, and rhabdomyolysis (cisplatin drug RANDA Injection package insert (2009)). Based on the information, the substance was classified into Category 1 (systemic toxicity).",
            "signal_word": "Danger",
            "symbol": "Health Hazard"
        },
        "systemic_toxicity_single_exposure": {
            "classification": "Category 1 (digestive system, bone marrow, kidney, nervous system)",
            "hazard_id": 8.0,
            "hazard_name": "Specific target organ toxicity - Single exposure",
            "hazard_statement": "Causes damage to organs (digestive system, bone marrow, kidney, nervous system)",
            "rationale": "The substance was used as an antineoplastic drug, so human toxicity data are available from adverse drug reaction reports for treated patients. There are no data for the oral, dermal and inhalation routes and it is difficult to determine whether a single dose or repeated doses were involved. The following symptoms are reported as the substance's acute toxicity: intractable nausea and vomiting as toxicity to the gut; leucopenia, thrombocytopenia as toxicity to the bone marrow (IARC vol. 26 (1981)), renal tubular function impairment as toxicity to the kidney, decreased hearing, \"thick\" speech, impairment of taste, numbness of hands, gait disturbances, loss of reduction of deep tendon reflexes, disorientation, paranoia, sensory function loss and motor function loss as toxicity to the nervous system (PIM 132 (1992)). The substance was classified into Category 1 (alimentary system, bone marrow, kidney, nervous system). As relevant information, mild and transient liver toxicity has occurred (PIM 132 (1992)). However, this information was not used as the basis of classification since there is a report that rarer risks include hepatic effects (PIM 132 (1992)).",
            "signal_word": "Danger",
            "symbol": "Health Hazard"
        }
    },
    "list_rating": 2,
    "list_type": "Screening A",
    "source": "GHS Japan Country List",
    "translated_data": {
        "AA": 0,
        "AT": 5,
        "B": 0,
        "C": 4,
        "CA": 0,
        "D": 4,
        "E": 0,
        "F": 0,
        "IrE": 4,
        "IrS": 2,
        "M": 4,
        "N_r": 4,
        "N_s": 4,
        "P": 0,
        "R": 4,
        "Rx": 2,
        "ST_r": 5,
        "ST_s": 5,
        "SnR": 0,
        "SnS": 2
    }
}